Clinical Trial Update: KRN7000 in Chronic Hepatitis B [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 trial of KRN7000 (alpha-galactosylceramide) in chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• KRN7000 (alpha-galactosylceramide)

Snippet

Sponsor: Foundation for Liver Research | Conditions: Hepatitis B, Chronic | Phase 1, Phase 2 | Status: COMPLETED